World's Best Scientists 2026 revealed!
Joost C. M. Meijers

Joost C. M. Meijers

D-Index & Metrics

Biology and Biochemistry

D-Index
92
Citations
28050
World Ranking
2232
National Ranking
49

Medicine

D-Index
93
Citations
30942
World Ranking
10913
National Ranking
431

Joost C. M. Meijers publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Joost C. M. Meijers sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 445 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Joost C. M. Meijers D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Joost C. M. Meijers sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 92 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Joost C. M. Meijers is affiliated with the University of Amsterdam in the Netherlands and has contributed extensively to the field of Medicine, with a particular focus on Hematology, Genetics, Cardiology and Cardiovascular Medicine, Internal Medicine, and Rheumatology. Their research portfolio includes over a hundred publications, with notable emphasis on blood coagulation and thrombosis mechanisms.

Their main research topics cover a range of areas related to hematology and cardiovascular medicine, including:

  • Blood Coagulation and Thrombosis Mechanisms
  • Platelet Disorders and Treatments
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Venous Thromboembolism Diagnosis and Management
  • Blood groups and transfusion
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Trauma, Hemostasis, Coagulopathy, Resuscitation

Meijers has published frequently in specialized journals, including:

  • Journal of Thrombosis and Haemostasis (15 publications)
  • Research and Practice in Thrombosis and Haemostasis (10 publications)
  • Thrombosis and Haemostasis (5 publications)
  • Seminars in Thrombosis and Hemostasis (3 publications)
  • Blood (3 publications)

Some recent papers authored or co-authored by Meijers highlight contributions to understanding hereditary angioedema, cardiovascular biomarkers, lupus anticoagulant mechanisms, cerebral venous thrombosis, and platelet activation in antiphospholipid syndrome. Notable examples of these papers are:

  • "Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema," 2020, New England Journal of Medicine
  • "MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability," 2020, Open Heart
  • "Anti-β2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action," 2021, Journal of Thrombosis and Haemostasis
  • "Prediction of cerebral venous thrombosis with a new clinical score and D-dimer levels," 2020, Neurology
  • "Antiprothrombin antibodies induce platelet activation: A possible explanation for anti-FXa therapy failure in patients with antiphospholipid syndrome?", 2021, Journal of Thrombosis and Haemostasis

Meijers regularly collaborates with a set of frequent co-authors, including:

  • Kamran Bakhtiari
  • Awital Bar Barroeta
  • J. Arnoud Marquart
  • Philip G. de Groot
  • Rolf T. Urbanus

Best Publications

  • Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.

    Elise S. Eerenberg;Pieter Willem Kamphuisen;Meertien K. Sijpkens;Joost C. Meijers

  • High levels of coagulation factor XI as a risk factor for venous thrombosis.

    Joost C.M. Meijers;Winnie L.H. Tekelenburg;Bonno N. Bouma;Rogier M. Bertina

  • Loss of Endothelial Glycocalyx During Acute Hyperglycemia Coincides With Endothelial Dysfunction and Coagulation Activation In Vivo

    Max Nieuwdorp;Timon W. van Haeften;Mirella C.L.G. Gouverneur;Hans L. Mooij

  • Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation.

    Kamran Bakhtiari;Joost C M Meijers;Evert de Jonge;Marcel Levi

  • Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1

    Mirjam E. Meltzer;Mirjam E. Meltzer;Ton Lisman;Ton Lisman;Philip G. de Groot;Joost C.M. Meijers

  • KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium

    Rob J. Dekker;Reinier A. Boon;Mariska G. Rondaij;Astrid Kragt

  • Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis

    P. A. K. Von Dem Borne;J. C. M. Meijers;B. N. Bouma

  • Hyperglycemia: a prothrombotic factor?

    B. A. Lemkes;J. Hermanides;J. H. Devries;F. Holleman

  • Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers

    Nick R. Bijsterveld;Arno H. Moons;S. Matthijs Boekholdt;Benien E. van Aken

  • Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo

    Marieke A.D. van Zoelen;Huan Yang;Sandrine Florquin;Joost C.M. Meijers

  • Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.

    Michiel E. Stegenga;Saskia N. van der Crabben;Regje M. E. Blümer;Marcel Levi

  • Thrombin-Activatable Fibrinolysis Inhibitor Deficiency in Cirrhosis Is Not Associated With Increased Plasma Fibrinolysis

    Ton Lisman;Frank W.G. Leebeek;Laurent O. Mosnier;Bonno N. Bouma

  • Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.

    Jan Rosing;Saskia Middeldorp;Joyce Curvers;M Christella L GDlig

  • Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.

    J. A. Koedam;J. C. M. Meijers;J. J. Sixma;B. N. Bouma

  • Review: Viral infections and mechanisms of thrombosis and bleeding.

    M. Goeijenbier;M. van Wissen;C. van de Weg;E. Jong

  • Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease

    Eduard J. van Beers;Marianne C.L. Schaap;René J. Berckmans;Rienk Nieuwland

  • Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.

    P. A. K. Von Dem Borne;L. Bajzar;J. C. M. Meijers;M. E. Nesheim

  • Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.

    Catharina Jacoba Maria Doggen;Frits R. Rosendaal;Joost C.M. Meijers

  • Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation

    L. O. Mosnier;P. A. K. Von Dem Borne;J. C. M. Meijers;B. N. Bouma

  • KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium

    Reinier A. Boon;Rob J. Dekker;Mariska G. Rondaij;Oscar L. Volger

Frequent Co-Authors

Marcel Levi
Marcel Levi University of Amsterdam
Tom van der Poll
Tom van der Poll University of Amsterdam
Bonno N. Bouma
Bonno N. Bouma Scripps Research Institute
Ton Lisman
Ton Lisman University Medical Center Groningen
Joris J. T. H. Roelofs
Joris J. T. H. Roelofs University of Amsterdam
Harry R. Büller
Harry R. Büller University of Amsterdam
Cornelis van 't Veer
Cornelis van 't Veer University of Amsterdam
Saskia Middeldorp
Saskia Middeldorp Radboud University Medical Center
Rienk Nieuwland
Rienk Nieuwland University of Amsterdam
Erik S.G. Stroes
Erik S.G. Stroes University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology or Biochemistry in the USA can open doors to broad career paths. With the rise of digital learning, many students now consider online degrees that blend life sciences with healthcare or management. One popular option is an affordable online mba in healthcare management, which equips graduates with both scientific knowledge and leadership skills for roles in hospitals, research organizations, and biotechnology firms.

Another alternative is a career in healthcare administration or medical data, such as billing and coding. Those interested in this direction will want to understand the distinction between certifications like cpc vs ccs, as these affect your career options and earning potential. If you're curious about income levels, see the current medical coding salary ranges, which can vary based on education, certification, and experience.

The healthcare data field offers good job stability and flexible work arrangements. For a balanced overview of your prospects, review the job outlook for medical billing and coding—helpful for anyone exploring alternative career pathways after a sciences degree.

Best Scientists Citing Joost C. M. Meijers

Trending Scientists

Recently Published Articles